Dr. Rothstein is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
1800 Orleans St.
Sheikh Zayed Tower
Baltimore, MD 21287Phone+1 410-614-5972- Is this information wrong?
Summary
- Dr. Jeffrey Rothstein is a neurologist in Baltimore, MD and is affiliated with Johns Hopkins Hospital. He received his medical degree from University of Illinois College of Medicine and has been in practice 32 years. He is experienced in general neurology and neuromuscular medicine.
Education & Training
Johns Hopkins UniversityResidency, Neurology, 1986 - 1989
University of North Carolina HospitalsInternship, Internal Medicine, 1985 - 1986
University of Illinois College of MedicineClass of 1985
Certifications & Licensure
MD State Medical License 1989 - 2025
PA State Medical License 2020 - 2022- American Board of Psychiatry and Neurology Neurology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2013
Clinical Trials
- Magnetic Resonance Imaging (MRI) in Amyotrophic Lateral Sclerosis (ALS) Start of enrollment: 2013 Jul 01
- Trial to Promote Recovery From COVID-19 With Endocrine Therapy Start of enrollment: 2021 Apr 01
Publications & Presentations
PubMed
- Nuclear pore dysfunction and disease: a complex opportunity.Charlotte M Fare, Jeffrey D Rothstein> ;Nucleus. 2024 Dec 1
- Apilimod dimesylate in C9orf72 amyotrophic lateral sclerosis: a randomized phase 2a clinical trial.Suma Babu, Katharine A Nicholson, Jeffrey D Rothstein, Andrea Swenson, Paul J Sampognaro, Pravin Pant, Eric A Macklin, Susan Spruill, Sabrina Paganoni, Tania F Gendron...> ;Brain. 2024 Apr 12
- 1 citationsMonocarboxylate transporters facilitate succinate uptake into brown adipocytes.Anita Reddy, Sally Winther, Nhien Tran, Haopeng Xiao, Josefine Jakob, Ryan Garrity, Arianne Smith, Martha Ordonez, Dina Laznik-Bogoslavski, Jeffrey D Rothstein, Evanna...> ;Nature Metabolism. 2024 Mar 1
- Join now to see all
Journal Articles
- Trial of Sodium Phenylbutyrate–Taurursodiol for Amyotrophic Lateral SclerosisSabrina Paganoni, Michael A Elliott, Samuel Maiser, Margaret A Owegi, Stephen A Goutman, Carlayne E Jackson, Jeffrey D Rothstein, Edward J Kasarskis, Liberty Jenkins, ..., The New England Journal of Medicine
- Motor Neuron-Derived microRNAs Cause Astrocyte Dysfunction in Amyotrophic Lateral SclerosisJeffrey D Rothstein, Nicholas J Maragakis, Timothy M Miller, Brain
Press Mentions
ALS Treatment: FDA to Rule on Drug Tofersen for Specific Type of the DiseaseApril 19th, 2023- Mitsubishi Tanabe Pharma America Presents Data on RADICAVA ORS® (Edaravone) at 2022 AANEM Annual MeetingSeptember 21st, 2022
- Pressured by Patients, FDA Reviews ALS Drug with Modest DataMarch 24th, 2022
- Join now to see all
Professional Memberships
- Member
Hospital Affiliations
Johns Hopkins HospitalBaltimore, Maryland
External Links
- Johns Hopkins Physicianshttp://www.hopkinsmedicine.org/jeffrey-rothstein
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
